A Phase 2a, Randomized, Active-Comparator-controlled, Open-Label Study to Evaluate the Efficacy and Safety of Efinopegdutide in Individuals with Non-Alcoholic Fatty Liver Disease
Journal of Hepatology（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined